Invention Grant
- Patent Title: Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
-
Application No.: US10992927Application Date: 2004-11-19
-
Publication No.: US07345060B2Publication Date: 2008-03-18
- Inventor: Mathai Mammen , Sarah Dunham
- Applicant: Mathai Mammen , Sarah Dunham
- Applicant Address: US CA South San Francisco
- Assignee: Theravance, Inc.
- Current Assignee: Theravance, Inc.
- Current Assignee Address: US CA South San Francisco
- Agent Jeffrey A. Hagenah; Connie C. Tong
- Main IPC: A61K31/445
- IPC: A61K31/445 ; C07D409/00
Abstract:
The invention is directed to compounds of formula I: wherein R1, R2, R3, R4, R5, R6, R7a, R7b, W, G1, G2, a, b, c, d and m are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention is also directed to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
Public/Granted literature
- US20050113417A1 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity Public/Granted day:2005-05-26
Information query
IPC分类:
